Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 5
2022 7
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
Borgoyakova MB, Karpenko LI, Rudometov AP, Shanshin DV, Isaeva AA, Nesmeyanova VS, Volkova NV, Belenkaya SV, Murashkin DE, Shcherbakov DN, Volosnikova EA, Starostina EV, Orlova LA, Danilchenko NV, Zaikovskaya AV, Pyankov OV, Ilyichev AA. Borgoyakova MB, et al. Mol Biol. 2021;55(6):889-898. doi: 10.1134/S0026893321050046. Epub 2021 Dec 17. Mol Biol. 2021. PMID: 34955558 Free PMC article.
A brief review on DNA vaccines in the era of COVID-19.
Shafaati M, Saidijam M, Soleimani M, Hazrati F, Mirzaei R, Amirheidari B, Tanzadehpanah H, Karampoor S, Kazemi S, Yavari B, Mahaki H, Safaei M, Rahbarizadeh F, Samadi P, Ahmadyousefi Y. Shafaati M, et al. Future Virol. 2021 Nov:10.2217/fvl-2021-0170. doi: 10.2217/fvl-2021-0170. Epub 2021 Nov 26. Future Virol. 2021. PMID: 34858516 Free PMC article. Review.
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.
Rudi E, Martin Aispuro P, Zurita E, Gonzalez Lopez Ledesma MM, Bottero D, Malito J, Gabrielli M, Gaillard E, Stuible M, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Rudi E, et al. Front Immunol. 2022 Sep 29;13:1020159. doi: 10.3389/fimmu.2022.1020159. eCollection 2022. Front Immunol. 2022. PMID: 36248791 Free PMC article.
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice.
Borgoyakova MB, Karpenko LI, Rudometov AP, Volosnikova EA, Merkuleva IA, Starostina EV, Zadorozhny AM, Isaeva AA, Nesmeyanova VS, Shanshin DV, Baranov KO, Volkova NV, Zaitsev BN, Orlova LA, Zaykovskaya AV, Pyankov OV, Danilenko ED, Bazhan SI, Shcherbakov DN, Taranin AV, Ilyichev AA. Borgoyakova MB, et al. Int J Mol Sci. 2022 Feb 16;23(4):2188. doi: 10.3390/ijms23042188. Int J Mol Sci. 2022. PMID: 35216301 Free PMC article.
Vaccines: Underlying Principles of Design and Testing.
Kallon S, Samir S, Goonetilleke N. Kallon S, et al. Clin Pharmacol Ther. 2021 Apr;109(4):987-999. doi: 10.1002/cpt.2207. Epub 2021 Mar 11. Clin Pharmacol Ther. 2021. PMID: 33705574 Free PMC article.
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.
Halwe S, Kupke A, Vanshylla K, Liberta F, Gruell H, Zehner M, Rohde C, Krähling V, Gellhorn Serra M, Kreer C, Klüver M, Sauerhering L, Schmidt J, Cai Z, Han F, Young D, Yang G, Widera M, Koch M, Werner A, Kämper L, Becker N, Marlow MS, Eickmann M, Ciesek S, Schiele F, Klein F, Becker S. Halwe S, et al. Viruses. 2021 Jul 29;13(8):1498. doi: 10.3390/v13081498. Viruses. 2021. PMID: 34452363 Free PMC article.
14 results